Establishing the diagnosis of HIV infection: New tests and a new algorithm for the United States

Journal of Clinical Virology

Volumn 52, Issue SUPPL. 1, 2011, Pages

  Branson, Bernard M ^a   Mermin, Jonathan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 2 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS RNA;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SCREENING; UNITED STATES; VIRUS LOAD; WESTERN BLOTTING;

ALGORITHMS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; UNITED STATES;

EID: 83155180369     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.09.024     Document Type: Note

References (25)

1. Ly T.D., Ebel A., Faucher V., Fihman V., Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?. J Virol Methods 2007, 143:86-94.
2. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008, 46:1588-1595.
3. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 52(Suppl 1):S17-S22.
4. Parry J.V., Mortimer P.P., Perry K.R., Pillay D., Zuckerman M. Towards error-free HIV diagnosis: guidelines on laboratory practice. Commun Dis Public Health 2003, 6:334-350.
5. CDC Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989, 38(Suppl. 7):S1-S7.
6. Haute Autorite De Sante. Public health guidelines: HIV infection screening in France, laboratory tests and algorithms 2008. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-02/hiv_infection_screening_in_france_-_laboratory_tests_and_algorithms-conclusions.pdf [accessed 06.08.11].
7. Australian Government Department of Health and Ageing. Requirements for Laboratory Testing for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) 2009. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/1210EF5BABF74134CA2571A10028C604/$file/Requirements%20for%20Lab%20Testing%20for%20HIV%20and%20HCV%20%28Second%20Edition%202009%29-final%20version-printing-27%20Nov%202009.doc.pdf [accessed 06.08.11].
8. CLSI. Criteria for laboratory testing and diagnosis of HIV infection: approved guideline. CLSI Document M-53A. Wayne PA: Clinical and Laboratory Standards Institute; 2011.
9. Patel P., MacKellar D., Simmons P., Uniyal A., Gallagher K., Bennett B., et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170:66-74.
10. Torian L.V., Eavey J.J., Punsalang A.P., Pirillo R.E., Forgione L.A., Kent S.A., et al. HIV Type 2 in New York City, 2000-2008. Clin Infect Dis 2011, 51:1334-1342.
11. CDC HIV-2 Infection Surveillance-United States, 1987-2009. MMWR Morb Mortal Wkly Rep 2011, 60:985-988.
12. Branson B. Conference wrap-up: unified laboratory algorithm. Presented at: 2010 HIV Diagnostics Conference, Orlando, FL, March 24-26, 2010. Available at: http://hivtestingconference.org/PDF/Presentations/BransonSummary.pdf [accessed 06.08.11].
13. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. US Department of Health and Human Services; January 10, 2011. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf [accessed 06.08.11].
14. Lindback S., Thorstensson R., Karlsson A.C., van Sydow M., Flamholc L., Blaxhult A., et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. AIDS 2000, 14:2333-2339.
15. Ren J., Bird L.E., Chamberlain P.P., Stewart-Jones G.B., Stuart D.I., Stammers D.K. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to nonnucleoside inhibitors. Proc Natl Acad Sci U S A 2002, 99:14410-14415.
16. Pilcher C.D., Fiscus S.A., Nguyen T.Q., Foust E., Wolf L., Williams D., et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005, 352:1873-1883.
17. Patel P., Klausner J.D., Bacon O.M., Liska S., Taylor M., Gonzalez A., et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 2006, 42:75-79.
18. Cohen M.S., Shaw G.M., McMichael A.J., Haynes B.F. Acute HIV-1 infection. N Engl J Med 2011, 364(20):1943-1954.
19. Ma Z.M., Stone M., Piatak M., Schweighardt B., Haigwood N.L., Montefirori D., et al. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol 2009, 83:3288-3297.
20. Brenner B.G., Roger M., Routy J.P., et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007, 195:951-959.
21. Bell S.K., Little S.J., Rosenberg E.S. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 2010, 202(Suppl. 2):S278-S288.
22. Moore Z.S., McCoy S., Kuruc J., Hilton M., Leone P. Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infection. J Acquir Immune Defic Syndr 2009, 52:509-513.
23. Ackers M.L., Parekh B., Evans T.G., Berman P., Philips S., Allen M., et al. Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients. J Infect Dis 2003, 187:879-886.
24. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
25. Hecht F.M., Wellman R., Busch M.P., Webb M., Rosenberg E., Swanson M., et al. Identifying the early post-HIV antibody seroconversion period. J Infect Dis 2011, 204:526-533.